Release
AlphaGenome 2: Deciphering how cells read DNA to better understand disease
The Brief
- Google DeepMind announced AlphaGenome 2 on 2026-11-11.
- The model is described as predicting how DNA sequences and their variations affect specific human cell types and disease.
- The source is a short announcement; no technical details, benchmarks or independent evaluations are given in the provided material.
Why it matters
If the model's predictions hold up, it could help researchers interpret how DNA variants may influence particular cell types and disease risk, though the announcement alone does not show how accurate it is.
Who’s affected
- geneticists and genomics researchers studying disease-linked DNA variants
- AlphaGenome 2
- #genomics
- #dna
- #deep learning
- #alphagenome
- #variant effects
- #disease
Predicting how DNA sequences and their variations impact specific human cell types and disease.
Timeline
Google DeepMind published the AlphaGenome 2 announcement
Google DeepMind News
AlphaGenome 2: Deciphering how cells read DNA to better understand disease